Research ExplorerPublicationsA prospective study of health care resource utilisation and ...

A prospective study of health care resource utilisation and selected costs of schizophrenia in France.

Standard

A prospective study of health care resource utilisation and selected costs of schizophrenia in France. / Sarlon, Emmanuelle; Heider, Dirk; Millier, Aurélie; Azorin, Jean-Michel; König, Hans-Helmut; Hansen, Karina; Angermeyer, Matthias C; Aballéa, Samuel; Toumi, Mondher.

In: BMC HEALTH SERV RES, Vol. 12, 2012, p. 269-276.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Sarlon, E, Heider, D, Millier, A, Azorin, J-M, König, H-H, Hansen, K, Angermeyer, MC, Aballéa, S & Toumi, M 2012, 'A prospective study of health care resource utilisation and selected costs of schizophrenia in France.', BMC HEALTH SERV RES, vol. 12, pp. 269-276. https://doi.org/10.1186/1472-6963-12-269

APA

Sarlon, E., Heider, D., Millier, A., Azorin, J-M., König, H-H., Hansen, K., Angermeyer, M. C., Aballéa, S., & Toumi, M. (2012). A prospective study of health care resource utilisation and selected costs of schizophrenia in France. BMC HEALTH SERV RES, 12, 269-276. https://doi.org/10.1186/1472-6963-12-269

Vancouver

Sarlon E, Heider D, Millier A, Azorin J-M, König H-H, Hansen K et al. A prospective study of health care resource utilisation and selected costs of schizophrenia in France. BMC HEALTH SERV RES. 2012;12:269-276. https://doi.org/10.1186/1472-6963-12-269

Bibtex

@article{db6677917f144f1e99f030e47522fe84,
title = "A prospective study of health care resource utilisation and selected costs of schizophrenia in France.",
abstract = "Schizophrenia is among the most burdensome and costly illnesses worldwide. To estimate the cost of schizophrenia in France, a longitudinal study was carried out between 1998 and 2002. The main objective of this study was to describe and update the cost of schizophrenia in a longitudinal, representative sample of French patients. The second objective was to identify cost drivers in the treatment of schizophrenia.",
keywords = "Humans, Prospective Studies, France, Health Resources/*utilization, Schizophrenia/*economics, Humans, Prospective Studies, France, Health Resources/*utilization, Schizophrenia/*economics",
author = "Emmanuelle Sarlon and Dirk Heider and Aur{\'e}lie Millier and Jean-Michel Azorin and Hans-Helmut K{\"o}nig and Karina Hansen and Angermeyer, {Matthias C} and Samuel Aball{\'e}a and Mondher Toumi",
year = "2012",
doi = "10.1186/1472-6963-12-269",
language = "English",
volume = "12",
pages = "269--276",
journal = "BMC HEALTH SERV RES",
issn = "1472-6963",
publisher = "BioMed Central Ltd.",

}

RIS

TY - JOUR

T1 - A prospective study of health care resource utilisation and selected costs of schizophrenia in France.

AU - Sarlon, Emmanuelle

AU - Heider, Dirk

AU - Millier, Aurélie

AU - Azorin, Jean-Michel

AU - König, Hans-Helmut

AU - Hansen, Karina

AU - Angermeyer, Matthias C

AU - Aballéa, Samuel

AU - Toumi, Mondher

PY - 2012

Y1 - 2012

N2 - Schizophrenia is among the most burdensome and costly illnesses worldwide. To estimate the cost of schizophrenia in France, a longitudinal study was carried out between 1998 and 2002. The main objective of this study was to describe and update the cost of schizophrenia in a longitudinal, representative sample of French patients. The second objective was to identify cost drivers in the treatment of schizophrenia.

AB - Schizophrenia is among the most burdensome and costly illnesses worldwide. To estimate the cost of schizophrenia in France, a longitudinal study was carried out between 1998 and 2002. The main objective of this study was to describe and update the cost of schizophrenia in a longitudinal, representative sample of French patients. The second objective was to identify cost drivers in the treatment of schizophrenia.

KW - Humans

KW - Prospective Studies

KW - France

KW - Health Resources/utilization

KW - Schizophrenia/economics

KW - Humans

KW - Prospective Studies

KW - France

KW - Health Resources/utilization

KW - Schizophrenia/economics

U2 - 10.1186/1472-6963-12-269

DO - 10.1186/1472-6963-12-269

M3 - SCORING: Journal article

VL - 12

SP - 269

EP - 276

JO - BMC HEALTH SERV RES

JF - BMC HEALTH SERV RES

SN - 1472-6963

ER -